Clinical Endoscopy

Review

Post-polypectomy surveillance: the present and the future: Masau Sekiguchi, Takahisa Matsuda, Kinichi Hotta, Yutaka Saito; Clin Endosc 2022;55(4):489-495. Published online July 11, 2022; DOI: https://doi.org/10.5946/ce.2022.097

An appropriate post-polypectomy surveillance program requires the effectiveness of reducing colorectal cancer and safety. In addition, the post-polypectomy surveillance program should consider the burden of limited medical resource capacity, cost-effectiveness, and patient adherence. In this sense, a risk-stratified surveillance program based on baseline colonoscopy results is ideal. Major international guidelines for post-polypectomy surveillance, such as those from the European Union and the United States, have recommended risk-stratified surveillance programs. Both guidelines have recently been updated to better differentiate between high- and low-risk individuals. In both updated guidelines, more individuals have been downgraded to lower-risk groups that require less frequent or no surveillance. Furthermore, increased attention has been paid to the surveillance of patients who undergo serrated polyp removal. Previous guidelines in Japan did not clearly outline the risk stratification in post-polypectomy surveillance. However, the new colonoscopy screening and surveillance guidelines presented by the Japan Gastroenterological Endoscopy Society include a risk-stratified post-polypectomy surveillance program. Further discussion and analysis of unresolved issues in this field, such as the optimal follow-up after the first surveillance, the upper age limit for surveillance, and the ideal method for improving adherence to surveillance guidelines, are warranted.

Citations

Citations to this article as recorded by

Protocolo diagnóstico del seguimiento de pólipos colónicos
S. Redondo Evangelista, M. Sierra Morales, I. Bartolomé Oterino, P. García Centeno, A. Santos Rodríguez
Medicine - Programa de Formación Médica Continuada Acreditado.2024; 14(4): 219. CrossRef
Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
Yunho Jung
The Korean Journal of Internal Medicine.2024; 39(4): 563. CrossRef
Efficacy of Oral Sulfate Tablet and 2 L-Polyethylene Glycol With Ascorbic Acid for Bowel Preparation: A Prospective Randomized KASID Multicenter Trial
Yunho Jung, Hyun Gun Kim, Dong-Hoon Yang, Hyoun Woo Kang, Jae Jun Park, Dong Hoon Baek, Jaeyoung Chun, Tae-Geun Gweon, Hyeon Jeong Goong, Min Seob Kwak, Hyun Jung Lee, Soo-Kyung Park, Jong Hoon Lee
Journal of Korean Medical Science.2024;[Epub] CrossRef
Metabolic‐associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Jiwon Chang, Yoosoo Chang, Yoosun Cho, Hyun‐Suk Jung, Dong‐Il Park, Soo‐Kyung Park, Soo‐Youn Ham, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
Liver International.2023; 43(11): 2548. CrossRef
Detecting colorectal lesions with image-enhanced endoscopy: an updated review from clinical trials
Mizuki Nagai, Sho Suzuki, Yohei Minato, Fumiaki Ishibashi, Kentaro Mochida, Ken Ohata, Tetsuo Morishita
Clinical Endoscopy.2023; 56(5): 553. CrossRef
Strategy for post-polypectomy colonoscopy surveillance: focus on the revised Korean guidelines
Yong Soo Kwon, Su Young Kim
Journal of the Korean Medical Association.2023; 66(11): 652. CrossRef
Endoscopic treatment of colorectal polyps and early colorectal cancer
Yunho Jung
Journal of the Korean Medical Association.2023; 66(11): 642. CrossRef
Understanding colorectal polyps to prevent colorectal cancer
Dong-Hoon Yang
Journal of the Korean Medical Association.2023; 66(11): 626. CrossRef

4,514 View
278 Download
6 Web of Science
8 Crossref

Original Article

Reduced Intravenous Fluorescein Dose for Upper and Lower Gastrointestinal Tract Probe-Based Confocal Laser Endomicroscopy: Kazuya Inoki, Seiichiro Abe, Yusaku Tanaka, Koji Yamamoto, Daisuke Hihara, Ryoji Ichijima, Yukihiro Nakatani, HsinYu Chen, Hiroyuki Takamaru, Masau Sekiguchi, Masayoshi Yamada, Taku Sakamoto, Satoru Nonaka, Haruhisa Suzuki, Shigetaka Yoshinaga, Ichiro Oda, Takahisa Matsuda, Yutaka Saito; Clin Endosc 2021;54(3):363-370. Published online September 8, 2020; DOI: https://doi.org/10.5946/ce.2020.058

Abstract PDF PubReader ePub

Background
/Aims: Probe-based confocal laser endomicroscopy (pCLE) requires the administration of intravenous (IV) fluorescein. This study aimed to determine the optimal dose of IV fluorescein for both upper and lower gastrointestinal (GI) tract pCLE.
Methods
Patients 20 to 79 years old with gastric high-grade dysplasia (HGD) or colorectal neoplasms (CRNs) were enrolled in the study. The dose de-escalation method was employed with five levels. The primary endpoint of the study was the determination of the optimal dose of IV fluorescein for pCLE of the GI tract. The reduced dose was determined based on off-line reviews by three endoscopists. An insufficient dose of fluorescein was defined as the dose of fluorescein with which the pCLE images were not deemed to be visible. If all three endoscopists determined that the tissue structure was visible, the doses were de-escalated.
Results
A total of 12 patients with gastric HGD and 12 patients with CRNs were enrolled in the study. Doses were de-escalated to 0.5 mg/kg of fluorescein for both non-neoplastic duodenal and colorectal mucosa. All gastric HGD or CRNs were visible with pCLE with IV fluorescein at 0.5 mg/kg.
Conclusions
In the present study, pCLE with IV fluorescein 0.5 mg/kg was adequate to visualize the magnified structure of both the upper and lower GI tract.

Citations

Citations to this article as recorded by

Prospective assessment of probe‐based confocal laser endomicroscopy under direct cholangioscopic visualization for biliary strictures that could not be definitively diagnosed using endoscopic retrograde cholangiopancreatography (with video)
Yuki Tanisaka, Shomei Ryozawa, Masafumi Mizuide, Akashi Fujita, Ryuhei Jinushi, Ryuichi Watanabe, Ryo Sato, Tomoaki Tashima, Yumi Mashimo
DEN Open.2025;[Epub] CrossRef
Precision endoscopy in colorectal polyps' characterization and planning of endoscopic therapy
Francesco Vito Mandarino, Silvio Danese, Toshio Uraoka, Adolfo Parra‐Blanco, Yasuharu Maeda, Yutaka Saito, Shin‐Ei Kudo, Michael J. Bourke, Marietta Iacucci
Digestive Endoscopy.2024; 36(7): 761. CrossRef

5,462 View
118 Download
2 Web of Science
2 Crossref

Review

Metachronous Gastric Cancer Following Curative Endoscopic Resection of Early Gastric Cancer: Seiichiro Abe, Ichiro Oda, Takeyoshi Minagawa, Masau Sekiguchi, Satoru Nonaka, Haruhisa Suzuki, Shigetaka Yoshinaga, Amit Bhatt, Yutaka Saito; Clin Endosc 2018;51(3):253-259. Published online September 18, 2017; DOI: https://doi.org/10.5946/ce.2017.104

Abstract PDF PubReader ePub

This review article summarizes knowledge about metachronous gastric cancer (MGC) occurring after curative endoscopic resection (ER) of early gastric cancer (EGC), treatment outcomes of patients who developed MGC, and efficacy of Helicobacter pylori eradication to prevent MGC. The incidence of MGC following curative ER increases over time and is higher than in patients undergoing gastrectomy. Increasing age and multifocal EGC are independent risk factors for developing MGC. An MGC following curative ER is usually a small (<20 mm) and differentiated intramucosal cancer. Most MGC lesions are found at an early stage on semiannual or annual surveillance endoscopy and are successfully treated by further ER, with excellent long-term outcomes. Eradication of H. pylori may reduce the risk of MGC following ER of EGC, but further prospective studies with long-term outcomes are required. Surveillance endoscopy following gastric ER should be continued indefinitely, due to the risk of MGC even after successful H. pylori eradication. Risk stratification and tailored endoscopic surveillance schedules need to be developed.

Citations

Citations to this article as recorded by

Impact of endoscopy intervals on metachronous gastric cancer after endoscopic submucosal dissection: Comparison between 1 year and half‐a‐year
Yuichiro Ozeki, Kingo Hirasawa, Atsushi Sawada, Ryosuke Ikeda, Masafumi Nishio, Takehide Fukuchi, Ryosuke Kobayashi, Chiko Sato, Shin Maeda
Digestive Endoscopy.2024; 36(3): 332. CrossRef
High risk of multiple gastric cancers in Japanese individuals with Lynch syndrome
Nobuhiko Kanaya, Thijs A. van Schaik, Hideki Aoki, Yumiko Sato, Fumitaka Taniguchi, Kunitoshi Shigeyasu, Kokichi Sugano, Kiwamu Akagi, Hideyuki Ishida, Kohji Tanakaya
Annals of Gastroenterological Surgery.2024; 8(6): 1008. CrossRef
Clinical outcomes of ablation of gastric dysplasia with argon plasma coagulation
Mi Jin Oh, Sang Gyun Kim, Jiyoon Kim, Yun Suk Na, Seunghan Lee, Junhee Lee, Bokyung Kim, Hyunsoo Chung, Soo-Jeong Cho, Miquel Vall-llosera Camps
PLOS ONE.2024; 19(7): e0306934. CrossRef
Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer
Dong Chan Joo, Gwang Ha Kim
Gut and Liver.2024; 18(5): 781. CrossRef
Latest guideline of endoscopic submucosal dissection of early gastric cancer may not be suitable for Chinese patients: retrospective study findings from two centers
Yu Mei, Jianpeng Gao, Benyan Zhang, Tienan Feng, Wei Wu, Zhenggang Zhu, Zhenglun Zhu
Surgical Endoscopy.2024; 38(11): 6726. CrossRef
AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review
Shailja C. Shah, Andrew Y. Wang, Michael B. Wallace, Joo Ha Hwang
Gastroenterology.2024;[Epub] CrossRef
Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study
Yun Suk Na, Sang Gyun Kim, Soo-Jeong Cho
Gastric Cancer.2023; 26(2): 298. CrossRef
Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score
Andreia Rei, Raquel Ortigão, Mariana Pais, Luís P. Afonso, Pedro Pimentel-Nunes, Mário Dinis-Ribeiro, Diogo Libânio
Endoscopy.2023; 55(10): 909. CrossRef
Variation in the rate of detection of minute and small early gastric cancers at diagnostic endoscopy may reflect the performance of individual endoscopists
Daisuke Murakami, Masayuki Yamato, Yuji Amano, Takayoshi Nishino, Makoto Arai
BMJ Open Gastroenterology.2023; 10(1): e001143. CrossRef
Decision to perform additional surgery after non-curative endoscopic submucosal dissection for gastric cancer based on the risk of lymph node metastasis: a long-term follow-up study
Seunghan Lee, Sang Gyun Kim, Soo-Jeong Cho
Surgical Endoscopy.2023; 37(10): 7738. CrossRef
Helicobacter pylori Eradication Can Reverse Rho GTPase Expression in Gastric Carcinogenesis
Jue Lie Kim, Sang Gyun Kim, Enerelt Natsagdorj, Hyunsoo Chung, Soo-Jeong Cho
Gut and Liver.2023; 17(5): 741. CrossRef
Risk assessment of metachronous gastric cancer after endoscopic submucosal dissection based on endoscopic intestinal metaplasia
Chino Iizuka, Soichiro Sue, Sho Onodera, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Kuniyasu Irie, Hiroaki Kaneko, Shin Maeda
JGH Open.2023; 7(11): 783. CrossRef
Second gastric cancer after curative endoscopic resection of differentiated-type early gastric cancer: post-hoc analysis of a single-arm confirmatory trial
Masao Yoshida, Kohei Takizawa, Noriaki Hasuike, Hiroyuki Ono, Narikazu Boku, Tomohiro Kadota, Junki Mizusawa, Ichiro Oda, Naohiro Yoshida, Yusuke Horiuchi, Kingo Hirasawa, Yoshinori Morita, Yoshinobu Yamamoto, Manabu Muto, Masao Yoshida, Kohei Takizawa, H
Gastrointestinal Endoscopy.2022; 95(4): 650. CrossRef
Therapeutic approach to non-curative resection after endoscopic treatment in early gastric cancer
Eun Jeong Gong, Chang Seok Bang
Journal of the Korean Medical Association.2022; 65(5): 284. CrossRef
Assessment of Outcomes From 1-Year Surveillance After Detection of Early Gastric Cancer Among Patients at High Risk in Japan
Yoshinobu Yamamoto, Naohiro Yoshida, Tomonori Yano, Takahiro Horimatsu, Noriya Uedo, Noboru Kawata, Hiromitsu Kanzaki, Shinichiro Hori, Kenshi Yao, Seiichiro Abe, Chikatoshi Katada, Chizu Yokoi, Ken Ohata, Hisashi Doyama, Kenichi Yoshimura, Hideki Ishikaw
JAMA Network Open.2022; 5(8): e2227667. CrossRef
Management of patients with multiple primary сancer in the practice of a modern oncologist. Case report and literature review
D. A. Khlanta, G. P. Gens
Siberian journal of oncology.2022; 21(4): 147. CrossRef
Assigning a different endoscopist for each annual follow-up may contribute to improved gastric cancer detection rates
Shuhei Unno, Kimihiro Igarashi, Hiroaki Saito, Dai Hirasawa, Toru Okuzono, Yukari Tanaka, Masato Nakahori, Tomoki Matsuda
Endoscopy International Open.2022; 10(10): E1333. CrossRef
Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population
Mohsen Karbalaei, Masoud Keikha
World Journal of Gastrointestinal Surgery.2022; 14(8): 867. CrossRef
Follow-up after endoscopic resection for early gastric cancer in 3 French referral centers
Bernadette de Rauglaudre, Mathieu Pioche, Fabrice Caillol, Jean-Philippe Ratone, Anna Pellat, Romain Coriat, Jerôme Rivory, Thomas Lambin, Laetitia Dahan, Marc Giovanini, Maximilien Barret
iGIE.2022; 1(1): 49. CrossRef
Documento de posicionamiento de la AEG, la SEED y la SEAP sobre cribado de cáncer gástrico en poblaciones con baja incidencia
Joaquín Cubiella, Ángeles Pérez Aisa, Miriam Cuatrecasas, Pilar Díez Redondo, Gloria Fernández Esparrach, José Carlos Marín-Gabriel, Leticia Moreira, Henar Núñez, M. Luisa Pardo López, Enrique Rodríguez de Santiago, Pedro Rosón, José Miguel Sanz Anquela,
Gastroenterología y Hepatología.2021; 44(1): 67. CrossRef
Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancer
Mitsuaki Ishioka, Toshiyuki Yoshio, Yuji Miyamoto, Ken Namikawa, Yoshitaka Tokai, Shoichi Yoshimizu, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiaki Hirasawa, Tomohiro Tsuchida, Junko Fujisaki
Gastrointestinal Endoscopy.2021; 93(3): 557. CrossRef
Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP
Joaquin Cubiella, Ángeles Pérez Aisa, Miriam Cuatrecasas, Pilar Díez Redondo, Gloria Fernández Esparrach, José Carlos Marín-Gabriel, Leticia Moreira, Henar Núñez, M. Luisa Pardo López, Enrique Rodríguez de Santiago, Pedro Rosón, José Miguel Sanz Anquela,
Gastroenterología y Hepatología (English Edition).2021; 44(1): 67. CrossRef
Molecular risk markers related to local tumor recurrence at histological margin-free endoscopically resected early gastric cancers: A pilot study
Ho Suk Kang, Mi Jung Kwon, Premi Haynes, Yan Liang, Yuqi Ren, Hyun Lim, Jae Seung Soh, Nan Young Kim, Hye Kyung Lee
Pathology - Research and Practice.2021; 222: 153434. CrossRef
Characteristics of metachronous gastric neoplasms after curative endoscopic submucosal dissection for early gastric neoplasms
Shan-Shan Xu, Ning-Li Chai, Xiao-Wei Tang, En-Qiang Linghu, Sha-Sha Wang, Bao Li
Chinese Medical Journal.2021; 134(21): 2603. CrossRef
Consenso mexicano sobre detección y tratamiento del cáncer gástrico incipiente
M.E. Icaza-Chávez, M.A. Tanimoto, F.M. Huerta-Iga, J.M. Remes-Troche, R. Carmona-Sánchez, A. Ángeles-Ángeles, F.J. Bosques-Padilla, J.M. Blancas-Valencia, G. Grajales-Figueroa, O.V. Hernández-Mondragón, A.I. Hernández-Guerrero, M.A. Herrera-Servín, F.D. H
Revista de Gastroenterología de México.2020; 85(1): 69. CrossRef
The Mexican consensus on the detection and treatment of early gastric cancer
M.E. Icaza-Chávez, M.A. Tanimoto, F.M. Huerta-Iga, J.M. Remes-Troche, R. Carmona-Sánchez, A. Ángeles-Ángeles, F.J. Bosques-Padilla, J.M. Blancas-Valencia, G. Grajales-Figueroa, O.V. Hernández-Mondragón, A.I. Hernández-Guerrero, M.Á. Herrera-Servín, F.D. H
Revista de Gastroenterología de México (English Edition).2020; 85(1): 69. CrossRef
Long‐term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication
Gitark Noh, Nayoung Kim, Yonghoon Choi, Hye Seung Lee, Young Jae Hwang, Hee Jin Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
Journal of Gastroenterology and Hepatology.2020; 35(9): 1540. CrossRef
Metachronous Gastric Cancer: Another Hurdle for Successful Endoscopic Treatment for Early Gastric Cancer?
Moon Won Lee, Gwang Ha Kim
Gut and Liver.2020; 14(2): 145. CrossRef
Clinical Outcomes of Metachronous Gastric Cancer after Endoscopic Resection for Early Gastric Cancer
Jue Lie Kim, Sang Gyun Kim, Jung Kim, Jae Yong Park, Hyo-Joon Yang, Hyun Ju Kim, Hyunsoo Chung
Gut and Liver.2020; 14(2): 190. CrossRef
Chemoprevention of gastric cancer development afterHelicobacter pylorieradication therapy in an East Asian population: Meta-analysis
Mitsushige Sugimoto, Masaki Murata, Yoshio Yamaoka
World Journal of Gastroenterology.2020; 26(15): 1820. CrossRef
MULTIFOCAL EARLY GASTRIC CANCER IN A PATIENT WITH ATROPHIC GASTRITIS AND PERNICIOUS ANEMIA
Tommaso Zurleni, Michele Altomare, Giovanni Serio, Filippo Catalano
International Journal of Surgery Case Reports.2020;[Epub] CrossRef
Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study
Hyun Ju Kim, Yun Jin Kim, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
Gastrointestinal Endoscopy.2020; 92(3): 613. CrossRef
Gastric cancer prevention strategies: A global perspective
Leonardo Henry Eusebi, Andrea Telese, Giovanni Marasco, Franco Bazzoli, Rocco Maurizio Zagari
Journal of Gastroenterology and Hepatology.2020; 35(9): 1495. CrossRef
Metachronous Gastric Cancer Occurring after Endoscopic Resection of Early Gastric Cancer
Gwang Ha Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(4): 295. CrossRef
Somatic alterations and mutational burden are potential predictive factors for metachronous development of early gastric cancer
Kazuhiro Sakuta, Yu Sasaki, Yasuhiko Abe, Hidenori Sato, Masakuni Shoji, Takao Yaoita, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Takashi Kon, Ayumi Koseki, Sonoko Sato, Ryoko Murakami, Yuki Miyano, Yoshiyuki Ueno
Scientific Reports.2020;[Epub] CrossRef
Clinicopathologic Characteristics of Patients with Gastric Superficial Neoplasia and Risk Factors for Multiple Lesions after Endoscopic Submucosal Dissection in a Western Country
Gisela Brito-Gonçalves, Diogo Libânio, Pedro Marcos, Inês Pita, Rui Castro, Inês Sá, Mário Dinis-Ribeiro, Pedro Pimentel-Nunes
GE - Portuguese Journal of Gastroenterology.2020; 27(2): 76. CrossRef
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis
Shiyu Xiao, Sizhu Li, Liya Zhou, Wenjun Jiang, Jinzhe Liu
Journal of Gastroenterology.2019; 54(3): 226. CrossRef
Helicobacter pylori Eradication for Metachronous Gastric Cancer: An Unsuitable Methodology Impeding Broader Clinical Usage
Alexios-Fotios A. Mentis, Efthimios Dardiotis
Frontiers in Oncology.2019;[Epub] CrossRef
Common Locations of Gastric Cancer: Review of Research from the Endoscopic Submucosal Dissection Era
Su Jin Kim, Cheol Woong Choi
Journal of Korean Medical Science.2019;[Epub] CrossRef
UEG Week 2019 Poster Presentations

United European Gastroenterology Journal.2019; 7(S8): 189. CrossRef
Helicobacter pylori Infection following Endoscopic Resection of Early Gastric Cancer
Lan Li, Chaohui Yu
BioMed Research International.2019; 2019: 1. CrossRef
Prophylaxis and early diagnosis of stomach cancer
I. G. Bakulin, S. S. Pirogov, N. V. Bakulina, E. A. Stadnik, N. N. Golubev
Dokazatel'naya gastroenterologiya.2018; 7(2): 44. CrossRef
Linked Color Imaging and Blue Laser Imaging for Upper Gastrointestinal Screening
Hiroyuki Osawa, Yoshimasa Miura, Takahito Takezawa, Yuji Ino, Tsevelnorov Khurelbaatar, Yuichi Sagara, Alan Kawarai Lefor, Hironori Yamamoto
Clinical Endoscopy.2018; 51(6): 513. CrossRef

10,301 View
297 Download
38 Web of Science
43 Crossref

First
Prev
Page of 1
Next
Last

Search